Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Sircar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kanishka Sircar is a pathologist in Houston, TX and is affiliated with multiple hospitals in the area, including University of Texas M.D. Anderson Cancer Center and University of Texas M.D. Anderson Cancer Center. He received his medical degree from McGill University Faculty of Medicine and has been in practice 23 years. He also speaks multiple languages, including Bengali and French. He specializes in anatomic pathology.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Genitourinary Pathology, 2001 - 2002- Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2000 - 2001
McGill University Faculty of MedicineClass of 1994
Certifications & Licensure
TX State Medical License 2008 - 2025
American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- Examiner, Anatomic Pathology Royal College of Physicians and Surgeons of Canada, 2008
Publications & Presentations
PubMed
- Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma.Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Kiran L Malikayil, Devaki Shilpa Surasi
Journal for Immunotherapy of Cancer. 2025-02-12 - Spatial Distribution of Tumor Cells in Clear Cell Renal Cell Carcinoma Is Associated with Metastasis and a Matrisome Gene Expression Signature.Prahlad Bhat, Pheroze Tamboli, Kanishka Sircar, Kasthuri Kannan
Cancers. 2025-01-14 - Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial.Pavlos Msaouel, Kai Yu, Ying Yuan, Jianfeng Chen, Xinmiao Yan
Nature Communications. 2025-01-10
Press Mentions
Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell CarcinomaFebruary 5th, 2021
Committees
- Panelist, National Comprehensive Cancer Network Testicular Cancers Panel 2016 - Present
- Panelist, National Comprehensive Cancer Network Kidney and Testicular Cancers Panel 2011 - 2016
Other Languages
- Bengali, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
